Tech Company Financing Transactions
Genialis Funding Round
Genialis, operating out of Houston, secured $13 million from Debiopharm Innovation Fund, Taiwania Capital and First Star Ventures.
Transaction Overview
Company Name
Announced On
3/28/2023
Transaction Type
Venture Equity
Amount
$13,000,000
Round
Series A
Investors
Debiopharm Innovation Fund (Lead Investor)
Taiwania Capital (Lead Investor) (Ita Lu)
Proceeds Purpose
The company intends to use the funds to expand its proprietary ResponderID platform and build out its comprehensive collection of clinically validated biomarker models to provide pinpoint diagnoses for virtually every cancer patient.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
2520 Robinhood St. 603
Houston, TX 77005
USA
Houston, TX 77005
USA
Phone
Website
Email Address
Overview
Genialis, Inc. is a life sciences data software company based in Houston, Texas, Cambridge, Massachusetts, and Ljubljana, Slovenia. Genialis focuses on delivering a best-in-class user experience for biologists, while ensuring robust and reproducible data analysis at scale.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rafael Rosengarten
Chief Operating Officer
Tja�a Kutin
Chief Technical Officer
Miha �tajdohar
Co-Founder
Nejc �koberne
VP - Customer Service
Luka Ausec
Browse more venture capital transactions:
Prev: 3/28/2023: Silicon Microgravity venture capital transaction
Next: 3/28/2023: Right-Hand Cybersecurity venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC transactions on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs